Search Results - "Rusyn, A."

FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma by Sahin, U., Türeci, Ö., Manikhas, G., Lordick, F., Rusyn, A., Vynnychenko, I., Dudov, A., Bazin, I., Bondarenko, I., Melichar, B., Dhaene, K., Wiechen, K., Huber, C., Maurus, D., Arozullah, A., Park, J.W., Schuler, M., Al-Batran, S.-E.

“…Claudin 18.2 (CLDN18.2) is contained within normal gastric mucosa epithelial tight junctions; upon malignant transformation, CLDN18.2 epitopes become exposed…”
Get full text

EXPRESSION PATTERN OF miR-125b-2, -155, -221, AND -320a IS ASSOCIATED WITH RESPONSE OF BREAST CANCER PATIENTS TO TAMOXIFEN by Pridko, O, Borikun, T, Rossylna, O, Rishko, M, Rusyn, A V

“…Hormonal therapy is one of the main methods of comprehensive treatment of patients with locally advanced breast cancer (BC). Despite the intensive search for…”
Get more information

DENTAL STATUS FEATURES IN PATIENTS DURING ANTI-CANCER CHEMOTHERAPY (TRANSCARPATHIAN ANTITUMOR CENTER EXPERIENCE) by Helei, N, Kostenko, E, Rusyn, A, Helei, V

“…One of the most common complications of complex anticancer therapy is the development of various lesions of the oral cavity, including mucositis, which…”
Get more information

Efficacy and safety of CT-P6 versus reference trastuzumab in HER2-positive early breast cancer: updated results of a randomised phase 3 trial by Esteva, F. J., Baranau, Y. V., Baryash, V., Manikhas, A., Moiseyenko, V., Dzagnidze, G., Zhavrid, E., Boliukh, D., Stroyakovskiy, D., Pikiel, J., Eniu, A. E., Li, R. K., Rusyn, A. V., Tiangco, B., Lee, S. J., Lee, S. Young, Yu, S. Y., Stebbing, J.

“…Purpose Neoadjuvant CT-P6, a trastuzumab biosimilar, demonstrated equivalent efficacy to reference trastuzumab in a phase 3 trial of HER2-positive early-stage…”
Get full text

BIOLOGICAL HERMETICITY, MECHANICAL STRENGTH AND MORPHOLOGICAL CHARACTERISTICS OF ONE-ROW AND TWO-ROW COLON ANASTOMOSES by Rusyn, V, Chobey, S, Rusyn, A, Chernov, P, Dutko, O

“…Aim - comparison of biological hermeticity, mechanical strength and differences in morphological characteristics of one-row and two-row colon anastomoses. 20…”
Get more information

Non-Inferior Efficiency of Opiod-Free Analgesia Support Among Colorectal Cancer Patients During and After Surgical Treatment: Evidences of Open-Label Trial by Tenkach, O, Rusyn, A, Palahonych, E, Ivachevskyi, M, Balazh, O, Goncharuk-Komyn, M

Get full text

Phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H vs EU-Neulasta® in the prophylactic treatment of chemotherapy-induced neutropenia by Waller, C, Blakeley, C, Pennella, E, Bronchud, M.H, Mattano, L, Berzoy, O, Voitko, N, Adamchuk, H, Zautashvili, Z, Vinnyk, Y, Nemsadze, G, Dzagnidze, G, Shparyk, Y, Lytvyn, I, Rusyn, A, Popov, V, Láng, I, Sharma, R, Baczkowski, M, Kothekar, M

Get full text

Radical nephrectomy and thrombectomy in patients with renal cell cancer complicated by tumoral thrombosis of the renal vein and vena cava inferior by Rusyn, V I, Korsak, V V, Rusyn, A V, Boĭko, S O

“…Surgical treatment was conducted in 81 patients, suffering renocellular cancer (RCC), complicated by a renal vein and vena cava inferior thrombosis. According…”
Get full text

Dosimetric studies of e-, γ-, n- Irradiation fields of the M-30 microtron (18.5 mev) by Maslyuk, V., Pop, O., Obryk, B., Svatiuk, N., Hainish, J., Rusyn, A., Romanyuk, M., Megela, I.

“…The results of the implementation and study of the radiation characteristics of high-energy electron (e-), gamma (γ-), and neutron (n-) radiation fields of the…”
Get full text

Classification of arterial reocclusion of the femoro-popliteo-tibial segment for the choice of the reconstruction method by Rusyn, V I, Korsak, V V, Rusyn, A V, Osypenko, P V

“…The literature data, concerning the issues of terminology and classification of occlusion and reocclusion of the femoro-popliteo-tibial segment arteries were…”
Get more information

Double-blind, randomized phase III study to compare the efficacy and safety of trastuzumab and its biosimilar candidate CT-P6 in HER2 positive early breast cancer (EBC) by Esteva, F.J., Baranau, Y., Baryash, V., Manikhas, A., Moiseyenko, V., Dzagnidze, G., Zhavrid, E., Boliukh, D., Stroyakovskiy, D., Pikiel, J., Eniu, A., Komov, D., Zautashvili, Z., Morar-Bolba, G., Li, R.K., Lifirenko, I., Rusyn, A., Lee, S.J., Yu, S., Stebbing, J.

Get full text

Final results of the FAST study, an international, multicenter, randomized, phase II trial of epirubicin, oxaliplatin, and capecitabine (EOX) with or without the anti-CLDN18.2 antibody IMAB362 as first-line therapy in patients with advanced CLDN18.2+ gastric and gastroesophageal junction (GEJ) adenocarcinoma by Schuler, M., Al-Batran, S.-E., Zvirbule, Z., Manikhas, G., Lordick, F., Rusyn, A., Vinnyk, Y., Vynnychenko, I., Fadeeva, N., Nechaeva, M., Dudov, A., Gotovkin, E., Pecheniy, A., Bazin, I., Bondarenko, I., Melichar, B., Huber, C., Türeci, Ö, Sahin, U.

Get full text

256 - Phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H vs EU-Neulasta® in the prophylactic treatment of chemotherapy-induced neutropenia by Waller, C., Blakeley, C., Pennella, E., Bronchud, M.H., Mattano, L., Berzoy, O., Voitko, N., Adamchuk, H., Zautashvili, Z., Vinnyk, Y., Nemsadze, G., Dzagnidze, G., Shparyk, Y., Lytvyn, I., Rusyn, A., Popov, V., Láng, I., Sharma, R., Baczkowski, M., Kothekar, M.

Get full text

220O Claudin 18.2 - a novel treatment target in the multicenter, randomized, phase II FAST study, a trial of epirubicin, oxaliplatin, and capecitabine (EOX) with or without the anti-CLDN18.2 antibody IMAB362 as 1st line therapy in advanced gastric and gastroesophageal junction (GEJ) cancer by Lordick, F., Schuler, M., Al-Batran, S.-E., Zvirbule, Z., Manikhas, G., Rusyn, A., Vinnyk, Y., Vynnychenko, I., Fadeeva, N., Nechaeva, M., Dudov, A., Gotovkin, E., Pecheniy, A., Bazin, I., Bondarenko, I., Melichar, B., Huber, C., Sahin, U., Tu¨ reci, O.

Get full text

220O Claudin 18.2 – a novel treatment target in the multicenter, randomized, phase II FAST study, a trial of epirubicin, oxaliplatin, and capecitabine (EOX) with or without the anti-CLDN18.2 antibody IMAB362 as 1st line therapy in advanced gastric and gastroesophageal junction (GEJ) cancer by Lordick, F., Schuler, M., Al-Batran, S-E., Zvirbule, Z., Manikhas, G., Rusyn, A., Vinnyk, Y., Vynnychenko, I., Fadeeva, N., Nechaeva, M., Dudov, A., Gotovkin, E., Pecheniy, A., Bazin, I., Bondarenko, I., Melichar, B., Huber, C., Sahin, U., Türeci, Ö.

Get full text

Phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H vs EU-neulasta® in the prophylaxis of chemotherapy-induced neutropenia by Waller, C.F., Blakeley, C., Pennella, E., Bronchud, M., Berzoy, O., Voitko, N., Adamchuk, H., Zautashvili, Z., Vinnyk, Y., Nemsadze, G., Dzagnidze, G., Shparyk, Y., Lytvyn, I., Rusyn, A., Popov, V., Lang, I., Sharma, R., Baczkowski, M., Kothekar, M., Barve, A.

Get full text

Radiation therapy for brain stem tumor in children by Severyn, Y.P., Vintsevych, L.V., Stassiuk, M.B., Riebienkov, S.O., Rusyn, A.H., Karnaukhov, S.A., Popadiynets, O.P.

“…Background. Tumors of the central nervous system occupy the first place in the structure of causes of death from malignant tumors among children. The tumors of…”
Get full text

Кістозні лімфатичні мальформації кишечника та брижі в дітей: особливості клінічного перебігу та лікувальна тактика by D.S. Diehtiarova, I.M. Benzar, A.H. Rusyn, O.S. Godik

“…Лімфатичні мальформації (ЛМ) - це вроджені вади розвитку лімфатичних судин із порушенням їхньої диференціації з різноманітними клінічними проявами…”
Get full text

Grouping of UVCB substances with dose-response transcriptomics data from human cell-based assays by House, John S, Grimm, Fabian A, Klaren, William D, Dalzell, Abigail, Kuchi, Srikeerthana, Zhang, Shu-Dong, Lenz, Klaus, Boogard, Peter J, Ketelslegers, Hans B, Gant, Timothy W, Rusyn, Ivan, Wright, Fred A

“…The application of in vitro biological assays as new approach methodologies (NAMs) to support grouping of UVCB (unknown or variable composition, complex…”
Get full text

Indices of the external respiratory function in patients suffering from hepatic cirrhosis with ascitic syndrome by Rusyn, V I, Rusyn, A V, Patskan', B M, Rumiantsev, K Ie, Sheremet, A P

“…The changes of external respiration indices in the patients suffering hepatic cirrhosis, complicated by ascitis and portal hypertension, were studied…”
Get more information